Skip to main content
SpringerLink
Log in

Bronchopulmonary Dysplasia: Clinical Management

  • Chapter
  • First Online:
Manual of Neonatal Respiratory Care

  • 586 Accesses

Abstract

The management of the infant with BPD is aimed at maintaining adequate gas exchange while at the same time limiting the progression of the lung damage. The challenge is that the supplemental oxygen and mechanical ventilation needed to maintain gas exchange are some of the key factors implicated in the pathogenesis of the lung damage (Chap. 79).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • AAP. Postnatal Corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 2002;109:330–8.

    Article  Google Scholar 

  • Aschner JL. New therapies for pulmonary hypertension in neonates and children. Pediatr Pulmonol Suppl. 2004;26:132–5.

    Article  PubMed  Google Scholar 

  • Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349: 959–67.

    Article  CAS  PubMed  Google Scholar 

  • Atkinson SA. Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia. J Nutr. 2001;131:942S–6.

    CAS  PubMed  Google Scholar 

  • Bancalari E. Bronchopulmonary dysplasia. Semin Perinatol. 2003;8:1–92.

    Google Scholar 

  • Brunton JA, Saigal S, Atkinson S. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. J Pediatr. 1998;133:340–5.

    Article  CAS  PubMed  Google Scholar 

  • Buzzella B, Claure N, D’Ugard C, Bancalari E. A randomized controlled trial of two nasal continuous positive airway pressure levels after extubation in preterm infants. J Pediatr. 2014;164:46–51.

    Article  PubMed  Google Scholar 

  • Cole CH, Colton T, Shah BL, et al. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med. 1999;340:1005–10.

    Article  CAS  PubMed  Google Scholar 

  • D’Angio CT, Maniscalco WM. Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies. Paediatr Drugs. 2004;6:303–30.

    Article  PubMed  Google Scholar 

  • Doyle LW, Ehrenkranz RA, Halliday HL. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology. 2010;98:111–7.

    Article  CAS  PubMed  Google Scholar 

  • Greenough A. Update on patient-triggered ventilation. Clin Perinatol. 2001;28:533–46.

    Article  CAS  PubMed  Google Scholar 

  • Grier DG, Halliday HL. Corticosteroids in the prevention and management of BPD. Semin Neonatol. 2003;8:83–91.

    Article  PubMed  Google Scholar 

  • Kao LC, Durand DJ, McCrea RC, et al. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr. 1994;124:772–81.

    Article  CAS  PubMed  Google Scholar 

  • Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr. 2009;154(3):379–84.

    Article  CAS  PubMed  Google Scholar 

  • O’Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999;104:15–21.

    Article  PubMed  Google Scholar 

  • Onland W, Offringa M, De Jaegere AP, van Kaam AH. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials. Pediatrics. 2009;123:367–77.

    Article  PubMed  Google Scholar 

  • Reyes Z, Tauscher M, Claure N. Randomized, controlled trial comparing pressure support (PS) + synchronized intermittent mandatory ventilation (SIMV) with SIMV in preterm infants. Pediatr Res. 2004;55:466A.

    Article  Google Scholar 

  • Schmidt B, Roberts R, Millar D, Kirpalani H. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants. Neonatology. 2008;93:284–7.

    Article  PubMed  Google Scholar 

  • Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126:443–56.

    Article  PubMed  PubMed Central  Google Scholar 

  • SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362(21):1970–9.

    Article  PubMed Central  Google Scholar 

  • Tin W. Optimal oxygen saturation for preterm babies. Do we really know? Biol Neonate. 2004;85:319–25.

    Article  PubMed  Google Scholar 

  • Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med. 1999;340:1962–8.

    Article  CAS  PubMed  Google Scholar 

  • Wardle AJ, Wardle R, Luyt K, et al. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia. Arch Dis Child. 2013;98:613–7.

    Article  PubMed  Google Scholar 

  • Watterberg KL, Committee on Fetus and Newborn. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics. 2010;126:800–8.

    Article  PubMed  Google Scholar 

  • Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 1998;101:e1–8.

    Article  Google Scholar 

  • Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004;350: 1304–13.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA

    Eduardo Bancalari M.D.

Authors
  1. Eduardo Bancalari M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Bancalari M.D. .

Editor information

Editors and Affiliations

  1. C.S. Mott Children’s Hospital, University of Michigan Health System, Ann Arbor, Michigan, USA

    Steven M. Donn

  2. University of Durham, The James Cook University Hospital, Marton-in-Cleveland, Middlesbrough, United Kingdom

    Sunil K. Sinha

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bancalari, E. (2017). Bronchopulmonary Dysplasia: Clinical Management. In: Donn, S., Sinha, S. (eds) Manual of Neonatal Respiratory Care. Springer, Cham. https://doi.org/10.1007/978-3-319-39839-6_80

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-39839-6_80

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-39837-2

  • Online ISBN: 978-3-319-39839-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation